Technical Trend Improvement Spurs Upgrade
The primary driver behind the rating upgrade is a shift in the technical outlook. The technical grade for Yash Chemex has improved from bearish to mildly bearish, signalling a less negative momentum in the stock’s price action. Weekly and monthly technical indicators present a mixed but cautiously optimistic picture. The Moving Average Convergence Divergence (MACD) is bearish on a weekly basis but bullish monthly, while the Relative Strength Index (RSI) is bullish weekly with no clear monthly signal. Bollinger Bands remain bearish on both weekly and monthly charts, indicating some volatility and downward pressure, but the overall trend is less severe than before.
Other technical tools such as the Know Sure Thing (KST) indicator show bearishness weekly but bullishness monthly, and the Dow Theory indicates no clear weekly trend but a mildly bearish stance monthly. Daily moving averages remain bearish, suggesting short-term caution. Despite these mixed signals, the technical environment has improved enough to warrant a more positive outlook compared to the previous Strong Sell rating.
Valuation Moves from Very Attractive to Attractive
Alongside technical improvements, valuation metrics have also contributed to the upgrade. Yash Chemex’s valuation grade has shifted from very attractive to attractive, reflecting a modest re-rating of the stock. The company’s price-to-earnings (PE) ratio stands at 26.43, which is reasonable compared to peers such as Titan Biotech (PE 63.17) and Sanstar (PE 76.95), both classified as very expensive or expensive. The enterprise value to EBITDA ratio of 27.74 is elevated but still within an acceptable range for the sector.
Other valuation ratios include a price-to-book value of 1.55 and an enterprise value to capital employed of 1.43, both suggesting the stock is trading at a discount relative to its capital base. The PEG ratio is exceptionally low at 0.06, indicating that the stock’s price growth is not fully reflecting its earnings growth potential. Return on capital employed (ROCE) and return on equity (ROE) are modest at 4.37% and 4.46% respectively, which tempers enthusiasm but still supports the attractive valuation grade.
While markets shift, this one's charging ahead! This Micro Cap from Aquaculture shows the strongest momentum signals in current conditions. Don't miss out on this ride!
- - Strongest current momentum
- - Market-cycle outperformer
- - Aquaculture sector strength
Financial Trend: Mixed Signals Amid Positive Quarterly Results
Yash Chemex has demonstrated some positive financial momentum in recent quarters, with the latest Q3 FY25-26 results showing net sales of ₹34.30 crores, a robust growth of 25.50% quarter-on-quarter. Profit after tax (PAT) reached ₹0.84 crores, the highest recorded, alongside an earnings per share (EPS) of ₹0.82. These figures indicate operational improvements and a degree of earnings acceleration.
However, the company’s long-term financial fundamentals remain weak. Over the past five years, net sales have grown at a modest compound annual growth rate (CAGR) of 14.97%, while operating profit growth has been a mere 2.01%. The average ROCE over this period is a low 6.39%, signalling limited efficiency in capital utilisation. Additionally, the company’s ability to service debt is concerning, with an average EBIT to interest coverage ratio of just 1.74, highlighting vulnerability to financial stress.
Market Performance and Share Price Dynamics
Yash Chemex’s stock price has shown mixed returns relative to the broader market. Over the past week, the stock gained 4.96%, outperforming the Sensex which declined by 1.87%. However, the one-month return was negative at -2.05%, though still better than the Sensex’s -8.51%. Year-to-date, the stock has declined 23.89%, underperforming the Sensex’s -11.67% loss. Over the last year, the stock has delivered a strong 19.36% return, significantly beating the Sensex’s -3.52% performance.
Longer-term returns are less favourable, with a three-year loss of 18.38% compared to the Sensex’s 30.85% gain, and a five-year return of 51% slightly lagging the Sensex’s 55.39%. The stock’s 52-week high was ₹111.00, with a low of ₹46.54, and it currently trades near ₹59.87, indicating it remains well below its peak levels.
Technical Indicators in Detail
The technical upgrade is underpinned by a nuanced assessment of momentum and trend indicators. Weekly MACD remains bearish, suggesting short-term downward momentum, but the monthly MACD has turned bullish, signalling potential medium-term strength. The weekly RSI is bullish, indicating improving buying interest, though the monthly RSI remains neutral. Bollinger Bands are bearish on both weekly and monthly charts, reflecting ongoing volatility and price pressure.
Moving averages on a daily basis remain bearish, cautioning investors about short-term weakness. The KST indicator shows a bearish weekly reading but a bullish monthly trend, reinforcing the mixed technical picture. Dow Theory analysis finds no clear weekly trend but a mildly bearish monthly stance. Overall, these indicators suggest the stock is transitioning from a strongly negative technical phase to a more neutral or mildly bearish one, justifying the upgrade from Strong Sell to Sell.
Valuation Comparison with Peers
Within the chemicals industry, Yash Chemex’s valuation is comparatively attractive. Its PE ratio of 26.43 is significantly lower than Titan Biotech’s 63.17 and Sanstar’s 76.95, both classified as expensive or very expensive. The EV to EBITDA ratio of 27.74 is higher than some peers but still within a reasonable range given the company’s growth prospects. The PEG ratio of 0.06 is particularly notable, indicating the stock is undervalued relative to its earnings growth potential.
Other companies in the sector such as I G Petrochems and TGV Sraac are rated very attractive but differ in scale and financial health. Yash Chemex’s valuation upgrade reflects a market reassessment of its earnings trajectory and risk profile, though it remains a micro-cap with inherent volatility.
Yash Chemex Ltd or something better? Our SwitchER feature analyzes this micro-cap Miscellaneous stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Quality Assessment and Long-Term Outlook
Despite recent improvements, Yash Chemex’s overall quality rating remains weak. The company’s long-term fundamentals are challenged by modest profitability and growth. The average ROCE of 6.39% over five years is below industry standards, and the slow operating profit growth of 2.01% annually raises concerns about sustainable earnings expansion. The company’s debt servicing capacity is limited, with an EBIT to interest ratio of 1.74, indicating financial risk if earnings falter.
Nonetheless, the company has delivered positive results for five consecutive quarters, suggesting operational improvements. The highest quarterly PAT of ₹0.84 crores and EPS of ₹0.82 reflect some earnings momentum. However, investors should remain cautious given the micro-cap status and the stock’s historical volatility.
Conclusion: A Cautious Upgrade Reflecting Mixed Signals
The upgrade of Yash Chemex Ltd’s investment rating from Strong Sell to Sell is driven primarily by improved technical indicators and a more attractive valuation profile. While the company’s recent quarterly performance and market-beating one-year returns provide some optimism, long-term fundamental weaknesses and financial risks persist. The stock’s mixed technical signals and modest valuation improvement suggest a cautious stance for investors, with potential for further recovery if operational trends continue positively.
Given the micro-cap nature and sector volatility, investors should weigh these factors carefully and monitor upcoming quarterly results and market conditions closely before making significant portfolio decisions.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
